Astrazeneca shares extend rally after third-quarter 'beat and raise'
- Quarterly sales and earnings beat consensus- Group raises full-year earnings guidance - Currency headwinds seen increasingPharmaceutical giant AstraZeneca (AZN) delivered better than expected third quarter sales and profit growth...
10 November 2022